1. Market Research
  2. > Healthcare
  3. > Blood Supply, Tissue Banking and Transplantation Market Trends
  4. > A Product and Pipeline Analysis of the Global Immunoglobulin Market 

A Product and Pipeline Analysis of the Global Immunoglobulin Market : Trends in Communicable and Non-Communicable Diseases Drug Pipeline

Key Findings

Market Potential

Immunoglobulin (Ig) therapies are life-saving medicines. They have been in use for more than 60 years and provide the patient with a variety of antibodies that have proven to be beneficial for many. Often they are used as a last line of defense in many severe inflammatory diseases, and in some conditions, they are life-saving.

- However, immunoglobulin G (IgG) is an expensive therapy. In the United States, the cost per treatment varies from a few hundred dollars to thousands of dollars, depending on the individual's weight, dose requirements, and brand of IgG selected. In the United States, most health plans cover the cost of IgG.

- IgG can be administered in a medical facility, such a hospital or outpatient center. It can also be given in a physician's office or at a patient’s home.

- About % of IgG is used as an immunosuppressive treatment of a number of autoimmune disorders, with particularly large volumes consumed by neuropathies such as chronic inflammatory demyelinating polyneuropathy (CIDP).

- Globally, demand for immunoglobulin is continuously growing and the market is expected to foresee increased competition in the subcutaneous Ig segment.

Market Dynamics

In the next years, new participants such as Bharat Biotech (India) and Biotest (Germany) with pipeline products each (in mid-late stage clinical trials) are likely to compete with market leaders such as CSL Behring and Grifols.

- In 2015, CSL Behring (CSL), Baxter International, and Grifols were the top-three participants, accounting for % of the all-important US market for immunoglobulin-derived products.
- In between 2000 and 2015, a total of immunoglobulin products were approved, of which were approved for communicable diseases, while the remaining were approved for non-communicable diseases.
- The global IgG market is expected to reach a demand size of tons by 2020, up from an estimated tons in 2015.

Table Of Contents

A Product and Pipeline Analysis of the Global Immunoglobulin Market 
Table Of Contents
1 EXECUTIVE SUMMARY

Executive Summary
1. Key Findings
2. Key Findings
3. Major Milestones
4. Major Milestones
5. Scope of the Study

2 INTRODUCTION TO THE IMMUNOGLOBULIN MARKET

Introduction to the Immunoglobulin Market
1. Immunoglobulin Overview
2. Classification of Immunoglobulins
3. Classification of Immunoglobulins
4. Treatment Guidelines
5. Treatment Guidelines
6. Market Overview
7. Market Overview
8. Market Overview

3 IMMUNOGLOBULIN MARKET—MARKETED AND PIPELINE PRODUCTS

Immunoglobulin Market—Marketed and Pipeline Products
1. Overview of Drugs
2. Overview of Drugs
3. Competitive Landscape—Communicable Diseases Treatments
4. Competitive Landscape—Non-Communicable Diseases Treatments

4 COMMUNICABLE DISEASES PRODUCT ANALYSIS

Communicable Diseases Product Analysis
1. Communicable Diseases Product Overview
2. Marketed Product Analysis
3. Marketed Product Analysis
4. Marketed Product Analysis
5. Marketed Product Analysis
6. Marketed Product Analysis
7. Marketed Product Analysis
8. Pipeline Product Analysis
9. Pipeline Product Analysis

5 NON-COMMUNICABLE DISEASES PRODUCT ANALYSIS

Non-Communicable Diseases Product Analysis
1. Non-Communicable Diseases Product Overview
2. Marketed Product Analysis
3. Marketed Product Analysis
4. Marketed Product Analysis
5. Pipeline Product Analysis
6. Pipeline Product Analysis

6 IMMUNOGLOBULIN MARKET—PRODUCT DASHBOARDS

Immunoglobulin Market—Product Dashboards
1. Hizentra—CSL Behring
2. Civacir—Biotest
3. Flebogamma 10%—Grifols
4. GAMUNEX-C—Grifols
5. Privigen—CSL Behring
6. VariZIG—Cangene
7. Hepabulin IV—SK Holdings
8. Zutectra—Biotest
9. HyperTET—Grifols

7 KEY COMPANIES IN THE IMMUNOGLOBULIN MARKET

Key Companies in the Immunoglobulin Market
1. Baxter International Inc.
2. Biotest AG
3. China Biologics Products, Inc.
4. CSL Behring Limited
5. Grifols
6. Octapharma AG
7. Kedrion Biopharma

8 IMMUNOGLOBULIN MARKET—TIMELINE OF KEY EVENTS

Immunoglobulin Market—Timeline of Key Events
1. Estimated Key Product Launch Timeline
2. Approval Dates

9 FUTURE OF THE IMMUNOGLOBULIN MARKET

Future of the Immunoglobulin Market
1. Conclusions—Future of Immunoglobulin Market
2. Legal Disclaimer

10 THE FROST and SULLIVAN STORY

The Frost and Sullivan Story
1. The Frost and Sullivan Story
2. Value Proposition: Future of Your Company and Career
3. Global Perspective
4. Industry Convergence
5. 360º Research Perspective
6. Implementation Excellence
7. Our Blue Ocean Strategy

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Tissue Banking Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2014 - 2024

Tissue Banking Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2014 - 2024

  • $ 5795
  • Industry report
  • October 2016
  • by Transparency Market Research

Global Tissue Banking Market: Overview Tissue Banking devices are used to store tissues in controlled environment for quality, safety and effective use in different disease treatment. The report on global ...

Intravenous Immunoglobulin Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Intravenous Immunoglobulin Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • September 2016
  • by Transparency Market Research

Intravenous Immunoglobulin (IVIG) Market: Scope and Methodology This report on the global intravenous immunoglobulin (IVIG) market analyzes the current and future prospects of the market. The report comprises ...

Plasma Fractionation Market by Product, Application, End User - Global Forecast to 2021

Plasma Fractionation Market by Product, Application, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global plasma fractionation market is estimated to grow at a CAGR of 6.7% from 2016 to 2021, to reach USD 26.07 billion by 2021 from USD 18.84 billion in 2016. Growth in this market is mainly attributed ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.